Hansa Biopharma Welcomes Key Executive Appointments to Drive Growth and Innovation

Hansa Biopharma AB, a leading biopharmaceutical company, recently announced the appointment of three key executives to support its growth and innovation strategy. Kerstin Falck Lagercrantz, with over two decades of experience at Pfizer AB, will join as Vice President Corporate Affairs.

Sandra Frithiof, a seasoned HR professional with a background in various industries, has been appointed as Chief Human Resources Officer. Brian Gorman, an experienced legal officer, will take on the role of Chief Legal Officer and Corporate Secretary. These strategic appointments align with Hansa’s focus on expanding its market presence and advancing its pipeline of innovative therapies. The addition of these talented leaders will further strengthen Hansa’s leadership team and drive the company’s success in the biotech industry.

Read more from finance.yahoo.com